gastrorrhagia

(redirected from Upper gastrointestinal bleeding)
Also found in: Dictionary, Wikipedia.

gastrorrhagia

 [gas″tro-ra´jah]
hemorrhage from the stomach.

gas·tror·rha·gi·a

(gas'trō-rā'jē-ă),
Hemorrhage from the stomach.
Synonym(s): gastric hemorrhage
[gastro- + G. rhēgnymi, to burst forth]

gastrorrhagia

/gas·tror·rha·gia/ (-ra´jah) hemorrhage from the stomach.

gastrorrhagia

An older term for gastric haemorrhage.

gas·tror·rha·gi·a

(gas'trō-rā'jē-ă)
Hemorrhage from the stomach.
[gastro- + G. rhēgnymi, to burst forth]

gastrorrhagia

hemorrhage from the stomach.
References in periodicals archive ?
On March 11, 2017, upper gastrointestinal bleeding occurred with hemoglobin of 66 g/L, shock and gastric ulcer were diagnosed; antiplatelet therapy was discontinued and 6 units of red blood cells was transfused; then, the hemoglobin increased to 81 g/L on March 21, 2017.
The increased incidence of upper gastrointestinal bleeding in our study could also be due to increased use of aspirin and nonsteroidal anti-inflammatory drugs in Nigeria.
2010) International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding.
A fibreoptic endoscopic study of upper gastrointestinal bleeding at Bugando Medical Centre in northwestern Tanzania: a retrospective review of 240 cases.
Upper gastrointestinal bleeding in a Brazilian hospital: a retrospective study of endoscopic records.
Evaluation of three different tests for the detection of stool antigens to diagnose helicobacter pylori infection in patients with upper gastrointestinal bleeding.
Causes of severe upper gastrointestinal bleeding on the basis of endoscopic findings.
Short-term use of serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding.
Upper gastrointestinal bleeding associated with focal ulceration at the attachment base of a chronically retained endoscopic hemoclip.
Combining nonsteroidal anti-inflammatory drugs with selective serotonin reuptake inhibitors increased the risk of upper gastrointestinal bleeding by up to 90% beyond the baseline risk found for NSAID monotherapy, researchers reported.
3) Vast majority of patients present with upper gastrointestinal bleeding (65%), while other manifestations includes; retrosternal discomfort, epigastric pain and dysphagia.
Variability among nonsteroidal anti-inflammatory drags in risk of upper gastrointestinal bleeding.